Giacomina Massaro-Giordano, MD
Show Description +
Find out why Giacomina Massaro-Giordano, MD, considers cenegermin-bkbj ophthalmic solution 0.002% (Oxervate, Dompé) to be a game changer for the treatment of patients with neurotrophic keratitis (NK).
Posted: 9/11/2019
Giacomina Massaro-Giordano, MD
Find out why Giacomina Massaro-Giordano, MD, considers cenegermin-bkbj ophthalmic solution 0.002% (Oxervate, Dompé) to be a game changer for the treatment of patients with neurotrophic keratitis (NK).
Posted: 9/11/2019
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2019.
Please log in to leave a comment.